Subcutaneous recombinant human erythropoietin prevents chemotherapy-related anemia in patients with advanced cancer.

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)341-345
Number of pages5
JournalInternational Journal of Oncology
Volume1
Publication statusPublished - 1992

Cite this